LET Gel — Class III drug recall D-0140-2024
Terminated recall by Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop, reported 2023-12-13, distributed nationwide. Product Mix-up: Incorrect Product Formulation
| Recall number | D-0140-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop, Irving, TX, United States |
| Recall initiated | 2023-11-09 |
| Classified | 2023-12-06 |
| Reported by FDA | 2023-12-13 |
| Terminated | 2024-08-20 |
| Distributed | Nationwide (US) |
| Quantity | 190 syringes |
| NDC | 73271-1003-01 |
| Expiration dates | 2024-03-18 |
Product
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1
Reason for recall
Product Mix-up: Incorrect Product Formulation
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0140-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.